Global Hospital Pharmaceuticals Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 101

Report ID: 3048

With the massive rise in the hospitals across the globe, pharmaceutical companies can expect a promising rise in growth opportunities in the hospital pharmaceutical sector.
In 2018, the global Hospital Pharmaceuticals market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hospital Pharmaceuticals status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hospital Pharmaceuticals development in United States, Europe and China.

The key players covered in this study
Sanofi
Bristol-Myers Squibb
Roche
Merck
GlaxoSmithKline
AstraZeneca
...

Market segment by Type, the product can be split into
Anti-hypertensives
Dyslipidemia drugs
Alkylating Agents
Anti-metabolites
Hormonal Agents
Immunomodulating Agents
Miscellaneous Drugs
Anti-anxiety Agents
Anti-migraine Drugs
Antidepressant Drugs

Market segment by Application, split into
Cardiology
Oncology
Nephrology and Urology
Neurology
Pain
Infection

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hospital Pharmaceuticals status, future forecast, growth opportunity, key market and key players.
To present the Hospital Pharmaceuticals development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hospital Pharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hospital Pharmaceuticals Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-hypertensives
1.4.3 Dyslipidemia drugs
1.4.4 Alkylating Agents
1.4.5 Anti-metabolites
1.4.6 Hormonal Agents
1.4.7 Immunomodulating Agents
1.4.8 Miscellaneous Drugs
1.4.9 Anti-anxiety Agents
1.4.10 Anti-migraine Drugs
1.4.11 Antidepressant Drugs
1.5 Market by Application
1.5.1 Global Hospital Pharmaceuticals Market Share by Application (2014-2025)
1.5.2 Cardiology
1.5.3 Oncology
1.5.4 Nephrology and Urology
1.5.5 Neurology
1.5.6 Pain
1.5.7 Infection
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hospital Pharmaceuticals Market Size
2.2 Hospital Pharmaceuticals Growth Trends by Regions
2.2.1 Hospital Pharmaceuticals Market Size by Regions (2014-2025)
2.2.2 Hospital Pharmaceuticals Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Hospital Pharmaceuticals Market Size by Manufacturers
3.1.1 Global Hospital Pharmaceuticals Revenue by Manufacturers (2014-2019)
3.1.2 Global Hospital Pharmaceuticals Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hospital Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2 Hospital Pharmaceuticals Key Players Head office and Area Served
3.3 Key Players Hospital Pharmaceuticals Product/Solution/Service
3.4 Date of Enter into Hospital Pharmaceuticals Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hospital Pharmaceuticals Market Size by Type (2014-2019)
4.2 Global Hospital Pharmaceuticals Market Size by Application (2014-2019)

5 United States
5.1 United States Hospital Pharmaceuticals Market Size (2014-2019)
5.2 Hospital Pharmaceuticals Key Players in United States
5.3 United States Hospital Pharmaceuticals Market Size by Type
5.4 United States Hospital Pharmaceuticals Market Size by Application

6 Europe
6.1 Europe Hospital Pharmaceuticals Market Size (2014-2019)
6.2 Hospital Pharmaceuticals Key Players in Europe
6.3 Europe Hospital Pharmaceuticals Market Size by Type
6.4 Europe Hospital Pharmaceuticals Market Size by Application

7 China
7.1 China Hospital Pharmaceuticals Market Size (2014-2019)
7.2 Hospital Pharmaceuticals Key Players in China
7.3 China Hospital Pharmaceuticals Market Size by Type
7.4 China Hospital Pharmaceuticals Market Size by Application

8 Japan
8.1 Japan Hospital Pharmaceuticals Market Size (2014-2019)
8.2 Hospital Pharmaceuticals Key Players in Japan
8.3 Japan Hospital Pharmaceuticals Market Size by Type
8.4 Japan Hospital Pharmaceuticals Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hospital Pharmaceuticals Market Size (2014-2019)
9.2 Hospital Pharmaceuticals Key Players in Southeast Asia
9.3 Southeast Asia Hospital Pharmaceuticals Market Size by Type
9.4 Southeast Asia Hospital Pharmaceuticals Market Size by Application

10 India
10.1 India Hospital Pharmaceuticals Market Size (2014-2019)
10.2 Hospital Pharmaceuticals Key Players in India
10.3 India Hospital Pharmaceuticals Market Size by Type
10.4 India Hospital Pharmaceuticals Market Size by Application

11 Central & South America
11.1 Central & South America Hospital Pharmaceuticals Market Size (2014-2019)
11.2 Hospital Pharmaceuticals Key Players in Central & South America
11.3 Central & South America Hospital Pharmaceuticals Market Size by Type
11.4 Central & South America Hospital Pharmaceuticals Market Size by Application

12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hospital Pharmaceuticals Introduction
12.1.4 Sanofi Revenue in Hospital Pharmaceuticals Business (2014-2019)
12.1.5 Sanofi Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hospital Pharmaceuticals Introduction
12.2.4 Bristol-Myers Squibb Revenue in Hospital Pharmaceuticals Business (2014-2019)
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hospital Pharmaceuticals Introduction
12.3.4 Roche Revenue in Hospital Pharmaceuticals Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hospital Pharmaceuticals Introduction
12.4.4 Merck Revenue in Hospital Pharmaceuticals Business (2014-2019)
12.4.5 Merck Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hospital Pharmaceuticals Introduction
12.5.4 GlaxoSmithKline Revenue in Hospital Pharmaceuticals Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hospital Pharmaceuticals Introduction
12.6.4 AstraZeneca Revenue in Hospital Pharmaceuticals Business (2014-2019)
12.6.5 AstraZeneca Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details